The DOI matches its Crossref record; 65 of the 69 references it cites were found in a registry or an index; none of the 57 sources its claims cite is checked for support yet.
Novel approaches in treatment of pediatric anxiety
Open accessAbstract
Pediatric anxiety disorders have high prevalence rates andmorbidity and are associated with considerable functional impairment and distress. They may be predictors for the development of other psychiatric disorders and, without intervention, are more likely to persist into adulthood. While evidence-based pharmacological and behavioral interventions are currently available, there remains a sizable subset of youth who remain only partially treatment-responsive and therefore symptomatic following treatment. Novel methods of treatment, pharmacologic and non-pharmacologic, including acceptance and commitment therapy (ACT), attention bias modification (ABM), d-cycloserine (DCS) augmentation of cognitive behavioral treatment (CBT), and glutamatergic agents such as riluzole, are briefly introduced and discussed. © 2014 Faculty of 1000 Ltd.
Overview
CoChat Summary
TL;DR
This review argues that although CBT and SSRIs are effective first-line treatments for pediatric anxiety, up to 50% of youth still meet criteria after treatment, motivating novel approaches. It briefly reviews emerging pharmacologic and non-pharmacologic strategies, especially ACT, attention bias modification, d-cycloserine, and riluzole.
Key findings
- Pediatric anxiety disorders are common, with prevalence rates of 10% to 20%, and are linked to chronic impairment, comorbidity, and later anxiety or major depression if untreated.
- In a multisite study cited by the paper, response rates were 81% for sertraline + CBT, 60% for CBT monotherapy, 55% for sertraline monotherapy, and 24% for placebo.
- For attention bias modification (ABM), the paper reports:
- 2 sessions increased attention disengagement from threat in chronically anxious children (mean age 10 years),
- 4 sessions reduced clinician severity ratings in an RCT of children ages 8 to 14 years,
- and ABM plus daily CBT produced greater symptom reductions than CBT alone in youth ages 13 to 17 years in a residential setting.
- For riluzole in youth, a 12-week open-label study in 6 children/adolescents with treatment-resistant OCD found substantial symptom reduction in 4 of 6 participants, but a 12-week RCT in 60 youth found no significant difference versus placebo-augmented treatment.
- For d-cycloserine (DCS) in youth, the paper states that one published study in children with OCD ages 8 to 17 years found no significant differences versus CBT alone, though effect sizes on primary outcomes were d = 0.31–0.47.
Methods
- Narrative review of emerging treatments for pediatric anxiety disorders, with sections on non-pharmacologic and pharmacologic approaches.
- Draws on previously published studies in children and adolescents, including case studies, open-label trials, RCTs, and adult trials cited for mechanistic or translational support.
- Main analysis is descriptive synthesis of the literature rather than a new empirical dataset or meta-analysis.
Limitations
- The paper itself notes that empirical research specifically examining ACT for pediatric anxiety disorders is sparse, and that there is a dearth of evidence for ACT in this population.
- It also notes that the pediatric riluzole RCT may have been limited by sample characteristics and high rates of concomitant medications.
- Evident from the text: this is a brief review, so conclusions are based on a small and heterogeneous set of studies rather than pooled quantitative analysis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 27 Not checked · 5 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Still, a dearth of empirical research has specifically examined ACT for pediatric anxiety disorders.”
§ Novel approaches in treatment of pediatric anxiety > Non-pharmacological interventions > Acceptance and commitment therapy
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In youth, only one published study has examined DCS as an adjunct to E/RP [61].”
§ Novel approaches in treatment of pediatric anxiety > Pharmacological interventions > D-cycloserine
What the sources say
- Not matchedcites [61]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“In sum, glutamatergic activity at the NMDA receptor seems to be critically involved in the neural mechanisms of learning and memory [42].”
§ Novel approaches in treatment of pediatric anxiety > Pharmacological interventions > Cognitive enhancers
What the sources say
- Not matchedcites [42]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“In adult trials, DCS demonstrated augmenting effects in the treatment of specific phobia of heights, social phobia, panic disorder, and OCD [54-59].”
§ Novel approaches in treatment of pediatric anxiety > Pharmacological interventions > D-cycloserine
What the sources say
- Not matchedcites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [59]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“In a study of youth ages 13 to 17 years in a residential unit for severe anxiety, those who received ABM in addition to daily (weekday) CBT had significantly greater reductions in anxiety symptoms at post-treatment relative to those who received CBT alone [34].”
§ Novel approaches in treatment of pediatric anxiety > Non-pharmacological interventions > Attention bias modification
What the sources say
- Not matchedcites [34]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
14 more claims
Create a free account to see all 32 claims and every source verdict.
- Probably not a substantial claim. 5
- It may state two separate claims as one. 9
Citations
Cites
Acceptance and commitment therapy: model, processes and outcomes
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.06.006 · Cited by 6,587 · cited 2×
“ACT seeks to increase psychological flexibility through cognitive defusion and acceptance [14].”
Background(1999) · Cited by 5,934
Threat-related attentional bias in anxious and nonanxious individuals: a meta-analytic study.
Bar-Haim, Y., Lamy, D., Pergamin, L., Bakermans-Kranenburg, M. J., & van IJzendoorn, M. H. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.1.1 · Cited by 3,721
Attentional bias in emotional disorders
MacLeod, C., Mathews, A., & Tata, P. (1986) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.95.1.15 · Cited by 3,152 · cited 1×
“Most frequently, a computerbased dot-probe task is used, and the difference in response times in the identification of a visual probe when paired with threatening or neutral stimuli is used as the attention bias index [27,28].”
MethodHasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908
AMPA Receptor Trafficking and Synaptic Plasticity
Malinow, R., & Malenka, R. C. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142758 · Cited by 2,588 · cited 1×
“NMDA receptors have an established role in the induction of many forms of neuroplasticity best seen in long-term potentiation (LTP) [37-41].”
BackgroundPine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.56 · Cited by 1,753 · cited 2×
“When left untreated, anxiety in childhood is a predictor for anxiety disorders and major depression later in life [7].”
BackgroundCognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety
Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., Ginsburg, G. S., Rynn, M. A., McCracken, J., Waslick, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804633 · Cited by 1,442 · cited 1×
“Monotherapy and combination therapy (SSRIs + CBT) have been demonstrated to be efficacious in large comparative trials; one multisite study reported treatment response rates of 81% for sertraline + CBT combination therapy, 60% for CBT monotherapy, and 55% for sertraline monotherapy, relative to a 24% response rate for…”
MacLeod, C., Rutherford, E., Campbell, L., Ebsworthy, G., & Holker, L. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.1.107 · Cited by 1,334 · cited 1×
“Attention biases toward threat-related stimuli are postulated to contribute to the etiology and maintenance of anxiety disorders [25,26].”
BackgroundRegulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity
Lee, H.-K., Barbarosie, M., Kameyama, K., Bear, M. F., & Huganir, R. L. (2000) · Nature · doi:10.1038/35016089 · Cited by 1,116 · cited 1×
“NMDA receptors have an established role in the induction of many forms of neuroplasticity best seen in long-term potentiation (LTP) [37-41].”
Background
Cited by
Navigating the complex behavioral landscape of children in foster care and adopted families
Choi, A., & Kadam, S. J. (2025) · Korean Journal of Pediatrics · doi:10.3345/cep.2025.00822 · Cited by 2
“2 Likewise, adopted children encounter unique”
Phenomenology and Standard Care of OCD in Children and Adolescents
Greenberg, E., & GELLER, D. A. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108235655.014 · Cited by 3
Self-citation
Metadata
- Authors
- Park, J. M., & Geller, D. A.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Corresponding author
- Geller, Daniel A.
- Venue
- F1000Prime Reports
- Publisher
- Faculty Opinions Ltd
- Published
- 2014-05-06
- Volume
- 6
- Pages
- 30-30
- ISSN
- 2051-7599 (ISSN-L)
- PMC
- PMC4017908
- OpenAlex
- W2001960276
- Cited by
- 2
- References
- 69
- Citations by year
- 2025: 1 · 2019: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- F1000Prime Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- childhood anxiety disorders, treatment-resistant anxiety, acceptance and commitment therapy, attentional bias modification, D-cycloserine, riluzole, glutamatergic agents, non-pharmacological treatment, pharmacotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel approaches in treatment of pediatric anxiety. https://app.cochat.ai/papers/10.12703/p6-30
- The paper
- Park, J. M., & Geller, D. A. (2014). Novel approaches in treatment of pediatric anxiety. F1000Prime Reports. https://doi.org/10.12703/p6-30
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.